Standard BioTools Inc. (LAB)
NASDAQ · Manufacturing · Pharmaceutical preparations
LAB price, last 12 months
Key stats
- Previous close
- $0.7430
- Open
- $0.7413
- Day range
- $0.7109 – $0.7499
- 52-week range
- $0.6251 – $1.72
- Volume
- 422.7K
- Avg volume (20 days)
- 1.5M
- Market cap
- $290.5M
Performance
Technicals and fundamentals
About Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $290.5M